Date: April 3rd 2008


 

BioTrinity 2008 - Oxford, April 15-16, 2008

New VC to take part in Panel Discussion at BioTrinity 2008

Orion Healthcare Equity Partners is an exciting new international healtchare venture capital firm started by experienced investors, some with links to the Oxford BioCluster.  Zina Affas will represent Orion on the VC Panel Discussion scheduled to take place on the morning of April 16th at BioTrinity in Oxford. Zina was previously Life Sciences Partner at Atlas Venture.

Other key staff at Orion include Mark Carthy was key in Massachusetts-based Oxford Bioscience Parner's financing of Oxford-based PowderMed, and was a Non-Executive Director until its acquisition by Pfizer in October 2006 for approximately £218m.

In other additions to the programme David Phillips, SVP at BioFocus DPI will be giving a keynotes on "Building a leading European Biotechnology Company", including details of the strategy behind BioFocus's ADR listing and AIM de-listing undertaken earlier this year.

Continuing BioTrinity's financing alternatives theme, we are very pleased to announce participation by James Posnetts, Managing Director European Products from NYSE Euronext

 

Over 300 delegates already confirmed
215 companies already confirmed
Over 1000 partnering requests already made
Nearly 100 licensing opportunities already available

VCs and investment-side companies active at BioTrinity will include:

Abingworth - Tim Haines will be joining the Financing Alternatives panel on Day One

SR One - Deborah Harland, General Partner is partnering at BioTrinity (GSK corporate venturer)

Sofinnova - Graziano Seghezzi is partnering and joining the VC Panel Discussion on Day Two

Oxford Capital Partners - David Mott, Investment Director, is partnering, with Ted chairing the VC Panel Discussion on Day Two

MP Healthcare Venture Management - Jeffrey B Moore, VP, is partnering and joining the VC Panel Discussion (Mitsubishi Pharma corporate venturer)

The Wellcome Trust - Richard Seabrook, Head of  Business Development is partnering and joining the VC Panel Discussion

NYSE Euronext - James Posnetts, MD of European Products is chairing and partnering

Innovator Capital - Sanjeev Gogna, Director of Corporate Finance is partnering

Beer and Partners - Lawrence Fenelon, Associate, will be partnering for companies seeking angel financing in the £75,000 and £5 million range

Catalyst Venture Partners - Richard Turner, CEO,  will be partnering with early and growth stage technology companies

Noble Fund Managers - Stephane Mery, Director is partnering

CannacordAdams - Karl Keegan, MD is partnering and chairing the Financing Alternatives panel from 11 AM on April 15th

Over 900 one-to-one meeting requests have been placed by delegates in the BioTrinity partnering system, and over 300 delegates are confirmed from 215 companies already.

You still do have time to register, but the longer you leave it - the less time you have to use the partnering system before the meeting,
although we will be providing access to the partnering system during the meeting.

Can you afford to miss BioTrinity 2008? Register online now 

Four key facts about BioTrinity 2008 - Oxford

  • Largest biopartnering conference in South-East England
  • Partnering is live: meeting requests are climbing fast
  • Uniquely your meetings will be held in private rooms
  • Pharmas attending: Takeda, Kowa, AstraZeneca, Merck, Genzyme, Bristol-Myers Squib, Teba and Shire
  • The updated programme for BioTrinity has now been published online and can be downloaded: online programme

...........................................................................................

What other people think:

"...I would like to congratulate you on an excellent meeting.."
Tim Haines, Partner, Abingworth Management

"...Congratulations on such a good event. I had a very productive day with lots of organized and impromptu meetings - a very worthwhile event for me." Dr Charles Potter, CEO, Glide Pharma

"I am delighted to be speaking at BioTrinity 2008, which is an opportune platform on which we can discuss the recent milestones achieved in the development of TroVax, our lead cancer immunotherapy." Peter Nolan, SVP Commercial Development at Oxford BioMedica

Read testimonials...

...........................................................................................

Register now and start partnering:www.biotrinity.com

Register online now! www.biotrinity.com

............................................................................................

Contact details:

Jon Rees, Network Director, OBN
Suite L, Park House
11 Milton Park, Abingdon
Oxfordshire OX14 4RA
Tel. +44 (0) 1865 594640
Fax. +44 (0) 1235 835843
jon.rees@oxfordshirebioscience.net


Register online now at www.biotrinity.com

 

............................................................................................

BioTrinity sponsors

Stimutran 

Milton Park 

UK Trade & Investment Merck Sharpe 


Dohme  genzyme

 Grant Thornton Helvoet Pharma   SEHTA

  Thermo Fisher  Thomson  De Facto

 Manches RDP Giles Insurance Brokers

 Biotechnology Finance Advisory Service Pharma Ventures

............................................................................................

BioTrinity partners

BioSpectrum Drug 


Discovery Today   LBN 

European Biotechnology News TVLSN  BioProcessUK

Pharmalicensing    MedNous

............................................................................................

BioTrinity is organised by OBN

OBN 

 

© 2006-2008 OBN

<< Previous: Oxford BioMedica develops strategic development plan with the commercialisation of TroVax

| Archive Index |

Next: BioTrinity 2008 Oxford: 55 hours left to register online - partnering activity surges >>

(archive rss , atom )

this list's archives:


This list is for those who wish to stay informed about developments in the BioTrinity conference programme, to find out when there are new announcements, when the online partnering service and company profiles are online, presentation or sponsorship opportunities, and most importantly when registration opens!

BioTrinity - BioPartnering Meeting and Company Showcase
April 2nd-3rd 2009 - Oxford

Subscribe/Unsubscribe on BioTrinity - Keep me informed

* Required



Powered by Dada Mail 3.0.0 beta 3 - 05/19/08
Copyright © 1999-2008, Simoni Creative.

Go back to Visit the BioTrinity website